WA pharmaceutical company PharmAust Ltd will sell discovery chemistry subsidiary Mimotopes Pty Ltd to US-based Commonwealth Biotechnologies Inc for a scrip consideration of between $8.6 and $10.6 million, 16 months after PharmAust acquired the company.
26/07/2006 - 14:48
PharmAust sells Mimotopes for up to $10.6m
26/07/2006 - 14:48
